Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services...

Charles River Laboratories International, Inc. (CRL) has a valuation score of 75/100 (strong), profitability score of 24/100 (weak), financial health score of 60/100 (moderate), Piotroski F-Score of 6/9, Altman Z-Score of 2.30 (grey zone), revenue growth of +0.3% YoY.

Neutral

Analyst Consensus

Buy

Wall Street consensus estimates — not a PMP forecast · Updated Sep 1, 2026

Analyst Recommendations22 analysts · 2026-08-01
5
10
7
Strong Buy 5Buy 10Hold 7Sell 0Strong Sell 0

Recent Market Moves

See all CRL moves →
DateSessionPriceMoveZ-Score
Aug 6Pre-market$260.72+11.93%7.96
Aug 5Pre-market$253.00+8.06%5.38
Aug 5Regular$260.04+11.07%7.38
Aug 5After-hours$262.06+11.93%7.96
Charles River Laboratories International, Inc. (CRL) Valuation & P/E History →Charles River Laboratories International, Inc. (CRL) Financial Statements →
Share:

Explore More Stocks

AAPLMSFTNVDAGOOGLAMZNMETATSLAJPMWMTVView all stocks →